Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Sell
9,033
-475
-5% -$169K 1.8% 11
2025
Q4
$3.11M Buy
9,508
+155
+2% +$49.2K 1.66% 15
2025
Q3
$2.64M Hold
9,353
1.48% 17
2025
Q2
$2.61M Buy
9,353
+65
+0.7% +$18.4K 1.56% 16
2025
Q1
$2.89M Buy
9,288
+50
+0.5% +$14.8K 1.84% 11
2024
Q4
$2.41M Buy
9,238
+10
+0.1% +$2.97K 1.56% 16
2024
Q3
$2.97M Sell
9,228
-265
-3% -$86.7K 1.82% 11
2024
Q2
$2.97M Sell
9,493
-545
-5% -$160K 1.86% 10
2024
Q1
$2.85M Sell
10,038
-250
-2% -$73.2K 1.72% 15
2023
Q4
$2.96M Buy
+10,288
New +$2.8M 1.85% 11

Other funds holding AMGN

Cetera Trust Company's AMGN Position: Q1 2026 in Review

Cetera Trust Company reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $169K and leaving 9,033 shares worth $3.18M. The position accounts for 1.8% of the portfolio, ranked #11.

Cetera Trust Company first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cetera Trust Company held 9,033 shares of Amgen worth $3.18M as of Q1 2026.
  • Cetera Trust Company sold 475 Amgen shares in Q1 2026, an estimated $169K.
  • Amgen made up 1.8% of Cetera Trust Company's portfolio in Q1 2026, its #11 holding.
  • Cetera Trust Company first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.